Oesophageal cancer Cancer
Conditions
Interventions
Randomisation:
Participants are enrolled and randomized consecutively as they are found to be eligible for inclusion in the trial. Randomization is performed no later than 12 h before surgery. If a pa
Sponsors
Uppsala University
Eligibility
Sex/Gender
All
Age
18 Years to 90 Years
Inclusion criteria
Inclusion criteria: Adult (=18 years of age) patients undergoing minimally invasive oesophagectomy with gastric conduit reconstruction due to confirmed cancer (cT1 N+ or cT2-4a any N; M0-1)
Exclusion criteria
Exclusion criteria: 1. Epidural analgesia contraindicated, i.e., known uncontrollable hypersensitivity to the components of the chemotherapeutic agents used in the trial regimens 2. Use of anticoagulants precluding EDA use 3. No postoperative nasogastric tube 4. No ability to understand the study in terms of risk and benefits (including language difficulties) 5. The participant has any other severe acute or chronic medical or psychiatric condition or laboratory abnormality that would, in the judgment of the investigator, pose excess risk associated with study participation or that, in the judgment of the investigator, would make the patient inappropriate for entry into the trial
Countries
Denmark, Finland, Iceland, Italy, Norway, Sweden
Contacts
Public ContactLinnéa Pattersson
Outcome results
None listed